Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 6.80
+0.07 (1.04%)
At close: Dec 12, 2025
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 120.31 billion as of December 12, 2025. Its market cap has increased by 95.52% in one year.
Market Cap
120.31B
Enterprise Value
125.28B
Revenue
33.49B
Ranking
n/a
PE Ratio
28.53
Stock Price
6.80
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 120.31B, an increase of 36,360.63%. That is a compound annual growth rate of 26.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 120.31B | 106.51% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | 140.92B | 3.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 277.87B |
| Hansoh Pharmaceutical Group Company | 262.50B |
| JD Health International | 184.89B |
| Innovent Biologics | 143.36B |
| WuXi Biologics | 138.21B |
| Akeso | 108.14B |
| Sichuan Kelun-Biotech Biopharmaceutical | 97.38B |
| WuXi XDC Cayman | 88.53B |